Joseph Moloughney
1 vote
Repurposing of Meropenem and Nadifloxacin for Treatment of Burn Patients?
The escalating number of multidrug resistant pathogens has demanded the swift development of new and potent antibiotics (ref. 2). Metallo-β-lactamases (MBLs) continue to evolve, rendering the …
Received 14 September 2009 20:46 UTC; Posted 15 September 2009
Posted to: Pharmacology
